| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.043 | 0.3 |